# Subcutaneous Dexpanthenol Administration and Wound Epithelialization

> **NCT07395674** · NA · NOT_YET_RECRUITING · sponsor: **Dilara CANBAY OZDEMIR** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Wounds
- Diabetic Foot Ulcer
- Venous Leg Ulcers
- Arterial Ulcer

## Interventions

- **DRUG:** Dexpanthenol
- **OTHER:** Standard Wound Care

## Key facts

- **NCT ID:** NCT07395674
- **Lead sponsor:** Dilara CANBAY OZDEMIR
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-02
- **Primary completion:** 2028-08-02
- **Final completion:** 2028-12-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07395674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07395674, "Subcutaneous Dexpanthenol Administration and Wound Epithelialization". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07395674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*